articleActa Pharmaceutica Sinica BJan 28, 2026DIAMOND OA

Targeted intestinal barrier repair via probiotic-derived engineered outer membrane vesicles: A 3A1M strategy with antioxidant, anti-inflammatory, anti-ferroptotic, and microbiome modulation effects

Wenzhou Medical University · Tongji University · +2 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

Intestinal barrier disruption, driven by oxidative stress, ferroptosis, immune imbalance, and gut microbiota dysbiosis, plays a crucial role in inflammatory bowel disease (IBD) pathogenesis. Current treatments are often ineffective and cause side effects, emphasizing the need for novel therapies. Here, we have developed an engineered probiotic-derived outer membrane vesicle (OMV), GDO@CM, combining antioxidant gallic acid (GA) and anti-inflammatory H 2 S for targeted intestinal barrier repair. Constructed from Escherichia coli Nissle 1917 (EcN)-derived OMVs, GA and DATS are incorporated into the hydrophilic inner cavity and lipid bilayer, respectively, while mannose-decorated chitosan (CM) is electrostatically…

Citation impact

4
total citations
FWCI
41.35
Percentile
99%
References
76
Too recent for citation history.

Authors

17

Topics & keywords

Keywords
  • Inflammatory bowel disease
  • Immune system
  • Bacterial outer membrane
  • Tight junction
  • Inflammation
  • Reactive oxygen species
  • Stem cell
No related works found for this paper.

Funding